Cargando…
4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39(+) CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
BACKGROUND: Responses to immunotherapy vary between different cancer types and sites. Here, we aimed to investigate features of exhaustion and activation in tumor-infiltrating CD8 T cells at both the primary and metastatic sites in epithelial ovarian cancer. METHODS: Tumor tissues and peripheral blo...
Autores principales: | Leem, Galam, Park, Junsik, Jeon, Minwoo, Kim, Eui-Soon, Kim, Sang Wun, Lee, Yong Jae, Choi, Seong Jin, Choi, Baekgyu, Park, Seongyeol, Ju, Young Seok, Jung, Inkyung, Kim, Sunghoon, Shin, Eui-Cheol, Lee, Jung Yun, Park, Su-Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745695/ https://www.ncbi.nlm.nih.gov/pubmed/33335029 http://dx.doi.org/10.1136/jitc-2020-001650 |
Ejemplares similares
-
4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8(+) T Cells in Hepatocellular Carcinoma
por: Kim, Hyung‐Don, et al.
Publicado: (2019) -
Type 17 immunity promotes the exhaustion of CD8(+) T cells in cancer
por: Kim, Byung-Seok, et al.
Publicado: (2021) -
Strategies to reinvigorate exhausted CD8(+) T cells in tumor microenvironment
por: Guan, Qianting, et al.
Publicado: (2023) -
MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
por: Koh, Jiae, et al.
Publicado: (2020) -
CD39 Expression Identifies Terminally Exhausted CD8(+) T Cells
por: Gupta, Prakash K., et al.
Publicado: (2015)